- Zacks•16 days ago
Meridian Bioscience, Inc. (VIVO), a renowned life sciences company, recently signed an exclusive distribution agreement with Biofirm Technologies.
- GlobeNewswire•17 days ago
Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Continues Global Development, Signs Exclusive Partnership to Provide Portable Blood Lead Testing in Africa
CINCINNATI, March 07, 2017-- Meridian Bioscience, Inc. announced today that Magellan Diagnostics Inc., a business unit of Meridian since March 2016, has signed an exclusive distribution agreement with ...
- PR Newswire•last month
Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and The Western Union Company
NEW YORK, Feb. 17, 2017 /PRNewswire/ -- Aetna Inc. (AET) Lifshitz & Miller announces investigation on behalf of AET investors concerning AET's abandoned acquisition of Humana Inc. If you are an AET investor, ...
VIVO : Summary for Meridian Bioscience Inc. - Yahoo Finance
Meridian Bioscience, Inc. (VIVO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||12.00 x 200|
|Ask||15.60 x 100|
|Day's Range||12.70 - 13.00|
|52 Week Range||10.75 - 21.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.50|
|Dividend & Yield||0.50 (3.91%)|
|1y Target Est||N/A|